Telehealth Services Amid COVID-19 and Flexibility to Waive Co-pays, Coinsurance, and Deductibles.
Waiver of Telehealth co-pays, coinsurance, and deductibles during COVID-19 Outbreak.
Read MoreWaiver of Telehealth co-pays, coinsurance, and deductibles during COVID-19 Outbreak.
Read MoreThe changes in Florida’s Medicaid enrollment and participation rules and regulations require that many previously unlicensed behavior analysis entities seek either licensure as health care clinic or seek exemption from licensure. See our previous post for additional facts regarding same here. As a result, many behavior analysis providers will need to file for licensure with
Read MoreStarting the New Year in 2020 means that Behavior Analysis providers in Florida will need to have a health care clinic license or exemption from licensure in order to avoid possible Medicaid payment interruptions. The deadline for compliance is July 1, 2020, however, the time to submit an application is now. For additional information regarding
Read MoreAll Behavior Analysis group providers will need to establish proof of compliance with the health clinic licensure requirements in order to continue receiving payments from the Florida Medicaid program.
Read MoreDo not wait to speak to an experienced health care attorney for assistance with filing for a health care clinic license or exemption from licensure with Florida’s Agency for Health Care Administration.
Read MoreAs of January 30, 2019, there are no active Medicare Provider Enrollment Moratoria in any State, including Florida, or U.S. territories. On July 31, 2013, the the Centers for Medicare and Medicaid Services (CMS) first issued a temporary moratorium which affected providers who desired to or where in the process of enrolling as a home
Read MoreSection 465.018, Florida Statutes was amended in 2011, by HB 7095 to require every community pharmacy that dispenses Schedule II and Schedule III controlled substances to be re-permitted by July 1, 2012. All owners, officers, and prescription department managers of the community pharmacy will need to submit fingerprints to the Department of Health as part of the permitting process; and the community pharmacy must implement written policies and procedures for preventing controlled substance dispensing based upon fraudulent representations or invalid practitioner-patient relationships. To avoid disruptions to a business, community pharmacies are advised to begin the permitting process immediately. For assistance and guidance with applying for a community pharmacy permit, developing policies and procedures for preventing controlled substance dispensing fraud and abuse, or to appeal a permit denial or revocation, contact Rafael A. Gaitan, Esq. Mr. Gaitan has over 15 years experience in the health care industry, regularly representing pharmacies and pharmacist before regulatory bodies like the Florida Department of Health, and the Board of Medicine. Mr. Gaitan can be reached via e-mail at rgaitan@gaitanmorales.com or via telephone at 305.329.1462.
Read MoreJanuary 17, 2012. Today, the House Health & Human Services Quality Subcommittee passed a bill aimed at giving the Surgeon General more power to stop doctors who over-prescribe narcotics, but only after a rewrite removing the word “suspension” — a compromise worked out between the Florida Medical Association and Department of Health. Under the rewritten version of
Read More